Description
EssilorLuxottica’s Emerging Market Growth Strategy: Can It Be A Real Game Changer?
EssilorLuxottica’s recent call highlights the company’s robust performance in the first half of the year, with revenue growth of 7.3% at constant currency. This has been supported by strides in both traditional eyewear and innovative new products, indicating a strategic balance between maintaining core operations and expanding into new technological domains. Positively, EssilorLuxottica is making significant inroads into the MedTech space. The acquisition of Optegra Eye Clinics extends their offering to advanced diagnostics and therapies, positioning them strongly in the comprehensive eye care sector. The company also made significant advancements in smart eyewear, notably with the successful launch and exponential sales growth of the Ray-Ban Meta and the introduction of Oakley Meta, their first AI glasses for sports and lifestyle, which together promise to draw a substantial consumer base.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
